Cns Pharmaceuticals Inc (NASDAQ: CNSP) on Monday, soared 4.82% from the previous trading day, before settling in for the closing price of $0.12. Within the past 52 weeks, CNSP’s price has moved between $0.10 and $137.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
With a float of $31.56 million, this company’s outstanding shares have now reached $32.15 million.
Let’s determine the extent of company efficiency that accounts for 5 employees. In terms of profitability, gross margin is 46.21%, operating margin of -251276.17%, and the pretax margin is -251077.43%.
Cns Pharmaceuticals Inc (CNSP) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cns Pharmaceuticals Inc is 1.81%, while institutional ownership is 0.45%. The most recent insider transaction that took place on Feb 01 ’24, was worth 10,000. In this transaction Director of this company bought 33,333 shares at a rate of $0.30, taking the stock ownership to the 43,006 shares. Before that another transaction happened on Feb 01 ’24, when Company’s Director bought 33,333 for $0.30, making the entire transaction worth $10,000. This insider now owns 33,458 shares in total.
Cns Pharmaceuticals Inc (CNSP) Recent Fiscal highlights
As on 9/30/2022, Multinational firm has announced its last quarter scores, in which it reported -2.1 earnings per share (EPS) for the period topping the consensus outlook (set at -3.3) by 1.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Trading Performance Indicators
Cns Pharmaceuticals Inc (CNSP) is currently performing well based on its current performance indicators. A quick ratio of 0.31 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -128.91, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Cns Pharmaceuticals Inc (CNSP)
Looking closely at Cns Pharmaceuticals Inc (NASDAQ: CNSP), its last 5-days average volume was 1.64 million, which is a drop from its year-to-date volume of 1.98 million. As of the previous 9 days, the stock’s Stochastic %D was 37.79%. Additionally, its Average True Range was 0.02.
During the past 100 days, Cns Pharmaceuticals Inc’s (CNSP) raw stochastic average was set at 0.18%, which indicates a significant decrease from 38.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.00% in the past 14 days, which was lower than the 224.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1485, while its 200-day Moving Average is $10.9673. However, in the short run, Cns Pharmaceuticals Inc’s stock first resistance to watch stands at $0.1290. Second resistance stands at $0.1341. The third major resistance level sits at $0.1405. If the price goes on to break the first support level at $0.1175, it is likely to go to the next support level at $0.1111. Now, if the price goes above the second support level, the third support stands at $0.1060.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Key Stats
Market capitalization of the company is 3.99 million based on 1,443K outstanding shares. Right now, sales total 0 K and income totals -18,850 K. The company made 0 K in profit during its latest quarter, and -2,530 K in sales during its previous quarter.
